{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:40:18Z","timestamp":1792730418410,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["02-2016-037"],"award-info":[{"award-number":["02-2016-037"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.thromres.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T23:32:35Z","timestamp":1494545555000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-7219","authenticated-orcid":false,"given":"Ji Yun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beodeul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Mee","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.thromres.2017.05.010_bb0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.thromres.2017.05.010_bb0010","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1182\/blood-2010-11-321398","article-title":"Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia","volume":"117","author":"Barsam","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2017.05.010_bb0015","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/adc.71.3.251","article-title":"Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology","volume":"71","author":"Lilleyman","year":"1994","journal-title":"Arch. Dis. Child"},{"issue":"9078","key":"10.1016\/j.thromres.2017.05.010_bb0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(97)04143-3","article-title":"Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines","volume":"350","author":"Bolton-Maggs","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.thromres.2017.05.010_bb0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/08880010050122816","article-title":"Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration","volume":"17","author":"Zeller","year":"2000","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","article-title":"The incidence of idiopathic thrombocytopenic purpura in adults increases with age","volume":"94","author":"Frederiksen","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.010_bb0040","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the general practice research database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12185-011-0791-1","article-title":"Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review","volume":"93","author":"Kurata","year":"2011","journal-title":"Int. J. Hematol."},{"issue":"16","key":"10.1016\/j.thromres.2017.05.010_bb0055","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.thromres.2017.05.010_bb0060","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood-2014-06-582346","article-title":"Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients","volume":"124","author":"Khellaf","year":"2014","journal-title":"Blood"},{"issue":"9610","key":"10.1016\/j.thromres.2017.05.010_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"issue":"9664","key":"10.1016\/j.thromres.2017.05.010_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00043426-200302000-00009","article-title":"Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology\/Oncology, 2001","volume":"25","author":"Vesely","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MAJ.0b013e31827f4dd1","article-title":"Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists","volume":"347","author":"Lu","year":"2014","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bjh.13415","article-title":"Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012","volume":"170","author":"Michel","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/19371910903070333","article-title":"Introduction: health of the health care system in Korea","volume":"25","author":"Kim","year":"2010","journal-title":"Soc. Work Public Health"},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/19371911003648275","article-title":"Special issue on the national health care system of South Korea","volume":"25","author":"Kim","year":"2010","journal-title":"Soc. Work Public Health"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4258\/hir.2012.18.3.215","article-title":"Health insurance claim review using information technologies","volume":"18","author":"Park","year":"2012","journal-title":"Healthc. Inform Res."},{"key":"10.1016\/j.thromres.2017.05.010_bb0105","author":"Korean Statistical Information Services"},{"issue":"22","key":"10.1016\/j.thromres.2017.05.010_bb0110","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.2009.01247.x","article-title":"The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review","volume":"83","author":"Abrahamson","year":"2009","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.010_bb0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/ar2825","article-title":"Why are women predisposed to autoimmune rheumatic diseases?","volume":"11","author":"Oliver","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.010_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.autrev.2006.10.001","article-title":"Gender and autoimmunity","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/08035250410025294","article-title":"Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease","volume":"94","author":"Zeller","year":"2005","journal-title":"Acta Paediatr."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.010_bb0135","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2141.2010.08176.x","article-title":"Epidemiology of paediatric immune thrombocytopenia in the general practice research database","volume":"149","author":"Yong","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2001-15255","article-title":"Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany","volume":"27","author":"Sutor","year":"2001","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.010_bb0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2004-815628","article-title":"Childhood acute immune thrombocytopenic purpura: 20years later","volume":"29","author":"Blanchette","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"issue":"11","key":"10.1016\/j.thromres.2017.05.010_bb0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1542\/pir.26-11-401","article-title":"Thrombocytopenia during childhood: what the pediatrician needs to know","volume":"26","author":"Buchanan","year":"2005","journal-title":"Pediatr. Rev."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0160","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1542\/peds.2007-1129","article-title":"A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children","volume":"121","author":"Glanz","year":"2008","journal-title":"Pediatrics"},{"issue":"9299","key":"10.1016\/j.thromres.2017.05.010_bb0165","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","article-title":"Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study","volume":"358","author":"Kuhne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2017.05.010_bb0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/asheducation-2013.1.276","article-title":"Current management of immune thrombocytopenia","volume":"2013","author":"Neunert","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"2","key":"10.1016\/j.thromres.2017.05.010_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","article-title":"Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)","volume":"72","author":"Schwartz","year":"2003","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.010_bb0180","first-page":"72","article-title":"Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases","volume":"90","author":"Vianelli","year":"2005","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.thromres.2017.05.010_bb0185","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2017.05.010_bb0190","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood-2011-12-309153","article-title":"How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment","volume":"120","author":"Ghanima","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2017.05.010_bb0195","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7326\/0003-4819-151-8-200910200-00008","article-title":"Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study","volume":"151","author":"Thomsen","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.010_bb0200","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1538-7836.2010.03849.x","article-title":"Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study","volume":"8","author":"Thomsen","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.010_bb0205","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2141.1994.tb04810.x","article-title":"A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients","volume":"86","author":"Facon","year":"1994","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.010_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2257.2004.00643.x","article-title":"The use of vinca alkaloids in adult patients with refractory chronic idiopathic thrombocytopenia","volume":"26","author":"Sikorska","year":"2004","journal-title":"Clin. Lab. Haematol."},{"issue":"12","key":"10.1016\/j.thromres.2017.05.010_bb0215","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1182\/blood-2016-03-603365","article-title":"How I treat refractory immune thrombocytopenia","volume":"128","author":"Cuker","year":"2016","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T06:31:32Z","timestamp":1575613892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817303250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":43,"alternative-id":["S0049384817303250"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}